Medicinal Products

DICLOFENAC ARROW GENERIC 1%

Generic drug from Voltarene Emulgel
Therapeutic class: Rheumatology
Active ingredients: Diclofenac
laboratory: Arrow Generic

Gel
box of 1 tube of 100 g
All forms

Indication

· Tendinitis of the upper and lower limbs.

· Post-operative and post-traumatic edema.

· Symptomatic treatment of painful osteoarthritis of the fingers and knees.

Dosage DICLOFENAC ARROW GENERIC 1% gel box of 1 tube of 100 g

· Tendinitis of the upper and lower limbs.

· Post-operative and post-traumatic edema.

· Symptomatic treatment of painful osteoarthritis of the fingers and knees.

Against indications

This medicine is contraindicated in the following cases:

· From the beginning of the 6th month of pregnancy (see section on Pregnancy and lactation ),

· Allergy to diclofenac or substances of similar activity such as other non-steroidal anti-inflammatory drugs (NSAIDs), aspirin,

· Allergy to any of the excipients,

· Damaged skin, whatever the lesion: oozing dermatitis, eczema, infected lesion, burn or wound.

Generic Diclofenac Arrow Side Effects

Frequent cases

Skin reactions: rashes, eczema, erythema, dermatitis (including contact dermatitis).

Rare cases

Skin reactions: bullous dermatosis. Associated pruritus is sometimes observed.

Very rare cases and isolated cases

Cutaneous reactions: pustular rash, urticaria, purpura, local ulcerations.

Hypersensitivity reactions; angioneurotic edema (Quincke's edema).

Respiratory problems: The onset of asthma attack may be related in some subjects to an allergy to aspirin or to an NSAID. In this case, this medicine is contraindicated.

Other skin reactions: isolated cases of photosensitivity.

Other systemic effects of NSAIDs

They are a function of the transdermal passage of the active ingredient and therefore the amount of gel applied, the surface treated, the degree of cutaneous integrity, the duration of the treatment and the use or not of an occlusive dressing (digestive effects, renal).

Reporting of suspected adverse reactions

The reporting of suspected adverse reactions after authorization of the drug is important. It allows continuous monitoring of the benefit / risk ratio of the drug. Health professionals declare any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.

Popular Posts

Category Medicinal Products, Next Article